These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
772 related items for PubMed ID: 25668264
1. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. JAMA; 2015 Feb 10; 313(6):603-15. PubMed ID: 25668264 [Abstract] [Full Text] [Related]
2. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A. Lancet; 2016 Jan 30; 387(10017):435-43. PubMed ID: 26559744 [Abstract] [Full Text] [Related]
3. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Lancet; 2016 Mar 05; 387(10022):957-967. PubMed ID: 26724178 [Abstract] [Full Text] [Related]
4. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis. Wang J, Chen Y, Xu W, Lu N, Cao J, Yu S. PLoS One; 2019 Mar 05; 14(4):e0215362. PubMed ID: 30978254 [Abstract] [Full Text] [Related]
5. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis. Brunström M, Carlberg B. JAMA Intern Med; 2018 Jan 01; 178(1):28-36. PubMed ID: 29131895 [Abstract] [Full Text] [Related]
8. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM. Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154 [Abstract] [Full Text] [Related]
9. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis. Pinho-Gomes AC, Azevedo L, Copland E, Canoy D, Nazarzadeh M, Ramakrishnan R, Berge E, Sundström J, Kotecha D, Woodward M, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K, Blood Pressure Lowering Treatment Trialists’ Collaboration. PLoS Med; 2021 Jun 11; 18(6):e1003599. PubMed ID: 34061831 [Abstract] [Full Text] [Related]
12. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension. Wong GW, Laugerotte A, Wright JM. Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578 [Abstract] [Full Text] [Related]
17. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis. Malhotra R, Nguyen HA, Benavente O, Mete M, Howard BV, Mant J, Odden MC, Peralta CA, Cheung AK, Nadkarni GN, Coleman RL, Holman RR, Zanchetti A, Peters R, Beckett N, Staessen JA, Ix JH. JAMA Intern Med; 2017 Oct 01; 177(10):1498-1505. PubMed ID: 28873137 [Abstract] [Full Text] [Related]
18. Effect of intensive lowering of systolic blood pressure treatment on heart failure events: a meta-analysis of randomized controlled studies. Zhang Y, Liang M, Sun C, Qu G, Shi T, Min M, Wu Y, Sun Y. J Hum Hypertens; 2019 Sep 01; 33(9):648-657. PubMed ID: 31363149 [Abstract] [Full Text] [Related]